Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study

INTRODUCTION: Few data are available regarding ipragliflozin treatment in combination with glucagon-like peptide-1 (GLP-1) receptor agonists. The aim of this study was to evaluate the efficacy and safety of ipragliflozin in combination with GLP-1 receptor agonists in Japanese patients with inadequat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishihara, Hisamitsu, Yamaguchi, Susumu, Nakao, Ikko, Sakatani, Taishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064587/
https://www.ncbi.nlm.nih.gov/pubmed/29926400
http://dx.doi.org/10.1007/s13300-018-0455-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064587/
https://www.ncbi.nlm.nih.gov/pubmed/29926400
http://dx.doi.org/10.1007/s13300-018-0455-8

Ejemplares similares